Why are more sponsors turning to Armenia for clinical trials?

In his latest article, our CEO Steve Healy takes a closer look at Armenia’s growing role in global research — from regulatory timelines to logistics and infrastructure on the ground.

✔️ GCP-aligned framework
✔️ Fast approvals (3–4 months)
✔️ Strong local investigator base
✔️ Customs and VAT advantages for clinical supplies

If you're exploring new trial destinations in the region, this is worth a read

Back to the list